Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 189 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy

Macular Polypoidal Choroidal Vasculopathy (PCV) Phase 3 Korea, Republic of

A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Phase 2 China

Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)

Primary Immune Thrombocytopenia (ITP) Phase 3 United States
Turkey
Thailand
Spain
China
United Kingdom
Italy
Czech Republic
Belgium
Romania
Hungary
Argentina
France
Australia
Japan
Germany
Norway
Vietnam
Hong Kong
Austria
Malaysia
Mexico
Singapore
Bulgaria
View All

A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids

Primary Immune Thrombocytopenia Phase 3 United States
Turkey
Japan
Thailand
Spain
China
Italy
Czech Republic
Romania
Hungary
Argentina
India
Australia
Germany
Norway
Korea, Republic of
Malaysia
Taiwan
Belgium
Austria
United Kingdom
Philippines
Singapore
Netherlands
View All

A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia

Warm Autoimmune Hemolytic Anemia (wAIHA) Phase 3 United States
Israel
Japan
Italy
Thailand
Spain
France
Romania
Argentina
Australia
China
Hungary
Germany
Malaysia
United Kingdom
India
Singapore
Taiwan
View All

Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)

Systemic Lupus Erythematosus Phase 3 United States
Turkey
Spain
Thailand
China
Brazil
Portugal
Slovakia
Czech Republic
Poland
South Africa
Japan
Guatemala
Hungary
Israel
Bulgaria
Canada
Singapore
View All

Kesimpta (Ofatumumab) Pregnancy Registry

Multiple Sclerosis, Pregnancy United States

Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment

Advanced Breast Cancer Phase 4 India

Single Arm, Open Label Trial With Iptacopan Treatment for 24 Weeks, in Patients on Stable Regimen of Anti-C5 Who Switch to Iptacopan.

Paroxysmal Nocturnal Hemoglobinuria Phase 3 Germany
United States
Italy
Turkey
Spain
United Kingdom
France
Korea, Republic of
View All

Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps Korea, Republic of